awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36270115-3A3C812B-65F0-49F2-A604-C87590F82042
Q36270115-3A3C812B-65F0-49F2-A604-C87590F82042
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36270115-3A3C812B-65F0-49F2-A604-C87590F82042
Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review
P2860
Q36270115-3A3C812B-65F0-49F2-A604-C87590F82042
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36270115-3A3C812B-65F0-49F2-A604-C87590F82042
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
015154f7559a0a7e6ab1c36a57dc78dfad175e13
P2860
Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma.